Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

See Locations Near You

Summary

The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Men or women of nonchildbearing potential,
18-50 years old.
Healthy as determined by the investigator, including physical examination, laboratory test results, and medical history.

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

60

Study ID:

NCT00708903

Recruitment Status:

Completed

Sponsor:

Puma Biotechnology, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You


Tacoma Washington, 98418, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 1

Estimated Enrollment:

60

Study ID:

NCT00708903

Recruitment Status:

Completed

Sponsor:


Puma Biotechnology, Inc.

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider